Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Products
  • Mirabegron Extended-Release Tablets
Where it was sold

Nationwide in the USA

Nationwide

About this recall
Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.